Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; 18 of the 53 sources its claims cite were checked for support.
Abstract
Context: Polycystic ovary syndrome (PCOS) is a complex, chronic, and under-recognized disorder. Diagnosis experience may have lasting effects on well-being and self-management. Objective: To investigate PCOS diagnosis experiences, information provided, and concerns about PCOS. Design: Cross-sectional study using an online questionnaire. Setting: Recruitment via support group web sites in 2015 to 2016. Participants: There were 1385 women with a reported diagnosis of PCOS who were living in North America (53.0%), Europe (42.2%), or other world regions (4.9%); of these, 64.8% were 18 to 35 years of age. Main Outcome Measures: Satisfaction with PCOS diagnosis experience, satisfaction with PCOS information received at the time of diagnosis, and current concerns about PCOS. Results: One-third or more of women reported >2 years (33.6%) and ≥3 health professionals (47.1%) before a diagnosis was established. Few were satisfied with their diagnosis experience (35.2%) or with the information they received (15.6%). Satisfaction with information received was positively associated with diagnosis satisfaction [odds ratio (OR), 7.0; 95% confidence interval (CI), 4.9 to 9.9]; seeing ≥5 health professionals (OR, 0.5; 95% CI, 0.3 to 0.8) and longer time to diagnosis (>2 years; OR, 0.4; 95% CI, 0.3 to 0.6) were negatively associated with diagnosis satisfaction (independent of time since diagnosis, age, and world region). Women's most common concerns were difficulty losing weight (53.6%), irregular menstrual cycles (50.8%), and infertility (44.5%). Conclusions: In the largest study of PCOS diagnosis experiences, many women reported delayed diagnosis and inadequate information. These gaps in early diagnosis, education, and support are clear opportunities for improving patient experience.
Overview
CoChat Summary
TL;DR
In an international cross-sectional online survey of 1385 women with a reported PCOS diagnosis, many reported delayed diagnosis and low satisfaction with their diagnosis and the information received. Satisfaction with information was strongly associated with diagnosis satisfaction, while seeing more health professionals and longer time to diagnosis were negatively associated.
Key findings
- 33.6% reported >2 years to diagnosis, 47.1% saw ≥3 health professionals before diagnosis, only 35.2% were satisfied with their diagnosis experience, and only 15.6% were satisfied with information received at diagnosis.
- In multivariable analysis, satisfaction with information received was positively associated with diagnosis satisfaction (OR, 7.0; 95% CI, 4.9–9.9); seeing ≥5 health professionals (OR, 0.5; 95% CI, 0.3–0.8) and time to diagnosis >2 years (OR, 0.4; 95% CI, 0.3–0.6) were negatively associated, independent of time since diagnosis, age, and world region.
- Most common concerns were difficulty losing weight (53.6%), irregular menstrual cycles (50.8%), and infertility (44.5%).
- For support needs, 90.3% selected broadly available educational materials, 70.1% patient forums/workshops, 65.0% a consumer website, and 59.9% a regular PCOS email.
Methods
- Cross-sectional online questionnaire conducted in 2015–2016, disseminated via the websites of PCOS Challenge (United States) and Verity (United Kingdom), mailing lists, and social media; eligibility was age ≥18 years and a prior doctor diagnosis of PCOS.
- Of 1550 responses, 165 were excluded (1 aged <18 years, 67 without doctor diagnosis, 97 completing less than half the questionnaire), leaving 1385 women; 53.0% lived in North America, 42.2% in Europe, and 4.9% in other regions, and 64.8% were 18–35 years old.
- Analysis used Stata 12.1; categorical data were presented as counts/proportions, and univariable and multivariable logistic regression examined diagnosis experience, information provision, and current concerns, with P < 0.05 considered significant.
Limitations
- The paper states that PCOS diagnosis was self-reported, phenotypes were not identified, the questionnaire was not validated against medical records, recall bias was possible, selection bias was possible, the sample may not represent the general PCOS population, the questionnaire was English-only on two English-language websites, and the “other world regions” group was small and heterogeneous.
- Evident from the design: the cross-sectional survey cannot establish causality, and recruitment through PCOS support organizations may overrepresent women who are engaged with support groups or have unmet diagnosis/information needs.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 2 Not valid · 17 Not checked · 82 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
What the sources say
- Not checked — no full text of the sourcecites [4] 4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. [DOI] [PubMed] [Google Scholar] source
- Not matchedcites [23] 23. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Marrian G, eds. Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992:377–384. [Google Scholar]
We searched by its title and found no matching paper.
- Supportedcites [24] 24. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. [DOI] [PubMed] [Google Scholar] source
The Summary explicitly states that, because PCOS is a syndrome, no single test is available to establish its diagnosis. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
What the sources say
- Not checked — no full text of the sourcecites [4] 4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. [DOI] [PubMed] [Google Scholar] source
- Not matchedcites [23] 23. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Marrian G, eds. Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992:377–384. [Google Scholar]
We searched by its title and found no matching paper.
- Supportedcites [24] 24. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. [DOI] [PubMed] [Google Scholar] source
In “A Phenotypic Approach to Defining PCOS: Task Force Recommendations” (page not provided), the report says the hirsutism cutoff is unclear, testosterone measurements vary, and some clinical signs cannot be used reliably. These limitations support the claim that individual PCOS diagnostic criteria lack clarity. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
What the sources say
- Not checked — no full text of the sourcecites [4] 4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. [DOI] [PubMed] [Google Scholar] source
- Not matchedcites [23] 23. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Marrian G, eds. Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992:377–384. [Google Scholar]
We searched by its title and found no matching paper.
- Supportedcites [24] 24. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. [DOI] [PubMed] [Google Scholar] source
The 'Previous Definitions of PCOS' section says two definitions were in widespread use, and the 'Principal Recommendations' section discusses when NIH 1990, Rotterdam 2003, or AE-PCOS Society criteria may be appropriate. This supports the attributed claim that different sets of diagnostic criteria are used. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Women report gaining some or most of their information about PCOS from specialists and the Internet (18, 19, 33) and that the quality of available PCOS information varies (17, 19, 33).”
What the sources say
- Partly supportedcites [18] 18. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL. Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health. 2001;1(1):3. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results report that physicians provided a significant amount of PCOS counseling to respondents aged 26–34, and the Discussion describes doctors as important to patient education. But the paper’s mention of internet use concerns how participants accessed the questionnaire; the passages do not establish that respondents obtained PCOS information from the Internet. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [19] 19. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf). 2007;66(3):373–379. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [33] 33. Humphreys L, Costarelli V. Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome. J R Soc Promot Health. 2008;128(4):190–195. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, recent genetic analyses have found the same PCOS susceptibility loci in self-reported and rigorously diagnosed women with PCOS (38, 39).”
What the sources say
- Partly supportedcites [38] 38. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, Azziz R, Zhang Y, James RG, Olivier M, Kissebah AH, Stener-Victorin E, Legro RS, Dunaif A, Alvero R, Barnhart HX, Baker V, Barnhart KT, Bates GW, Brzyski RG, Carr BR, Carson SA, Casson P, Cataldo NA, Christman G, Coutifaris C, Diamond MP, Eisenberg E, Gosman GG, Giudice LC, Haisenleder DJ, Huang H, Krawetz SA, Lucidi S, McGovern PG, Myers ER, Nestler JE, Ohl D, Santoro N, Schlaff WD, Snyder P, Steinkampf MP, Trusse sourceExperimental — accuracy not yet measured
The Methods (Subjects; page unavailable) state that the PCOS cases met NIH diagnostic criteria, and the Discussion (page unavailable) identifies susceptibility loci found in those cases. Our copy does not compare those loci with loci in women whose PCOS was self-reported, so it does not establish the claimed overlap. (LLM, conf=0.86)
- Supportedcites [39] 39. Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, Lawlor DA, Laval G, Mathieson I, McCardle WL, Louwers Y, Meun C, Ring S, Scott RA, Sulem P, Uitterlinden AG, Wareham NJ, Thorsteinsdottir U, Welt C, Stefansson K, Laven JSE, Ong KK, Perry JRB. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464. [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary ma source
The Results section reports that all six PCOS association signals found in the combined analysis showed directionally concordant associations in follow-up studies of clinically validated cases, with no significant heterogeneity by case definition. The Discussion likewise describes validation of the loci identified using self-reported cases in cases defined by stringent clinical criteria. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 1 with their cited sources checked
Create a free account to see all 116 claims and to verify the 2 references still open.
- Probably not a substantial claim. 35
- It may state two separate claims as one. 24
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a large international cross-sectional study of women with PCOS aged 18‐45 years (N=1256), approximately 65% (n=816) reported dissatisfaction with information received from health care professionals and the need for self-directed research [55].”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [55]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our data is consistent with other reports of a protracted diagnosis of PCOS taking greater than two years, and associated with multiple visits to health professionals and examination by three or more physicians before a diagnosis [2, 30, 48].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are similar to global reports in which those affected by PCOS describe not adequately being informed by their health care practitioner, or were not referred to relevant sources of information at diagnosis, leading to overall dissatisfaction with their health care [2, 30, 31].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Polycystic Ovary Syndrome (PCOS) is the most common endocrine-metabolic disorder affecting 6%–20% of populations [1–4].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding is consistent with other studies, using focus groups and surveys, that report information provided at diagnosis was not sufficient to allow for improved knowledge and effective self-management of PCOS symptoms [2, 46, 48].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [2]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 1×
“PCOS affects health and wellbeing over the lifespan (5, 6).”
Self-citationNorman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Research works printed but not linked: 3
- [23]23. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Marrian G, eds. Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992:377–384. [Google Scholar]
- [35]35. World Health Organization Diabetes Country Profiles 2016. 2016. Available at: www.who.int/diabetes/country-profiles/en/#C. Accessed 28 April 2016. [Google Scholar]
- [36]36. World Health Organization Prevalence of Overweight, Ages 18+, 2010–2014 (Age Standardized Estimate). 2015. Available at: http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/overweight/atlas.html. Accessed 28 April 2016. [Google Scholar]
Cited by
Items 201–300 of 419
Onat, T., İnandıklıoğlu, N., Kara, M., Yalvaç, S., Türkler, C., Çıplak, B., & Altindag, M. M. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.1980516 · Cited by 10
“…polycystic ovary syndrome (PCOS) is the most common endocrinological disorder of the reproductive period in women, its diagnosis remains to be a challenge for clinicians due to the different phenotypes of the syndrome as well as its ethnic variations (Bozdag et al. 2016; Gibson-Helm et al. 2017).”
BackgroundAn Overview on the Assessment and Management of Polycystic Ovarian Syndrome
Alhazmi, R. A., Khayat, S. K., Albakri, M. H., Alruwaili, W. S., Bayazed, H. A., Almubarak, S. A., Albahrani, A. A., Alshahrani, A. A., Alharkan, A. A., & Alreqei, H. M. (2022) · World Journal of Environmental Biosciences · doi:10.51847/yaaa2745zy · Cited by 11
Sourouni, M., Estermann, J., Bitterlich, N., Weidlinger, S., Bachmann, A., & Stute, P. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07452-y · Cited by 12
“Gynaecologists could benefit from an improved understanding of PCOS during their residency training [7].”
Kaundal, A., Renjhen, P., & Kumari, R. (2023) · Cureus · doi:10.7759/cureus.36889 · Cited by 22
“Due to the complex presentation of the disease diagnosis is difficult and is often delayed [7-9].”
BackgroundJiskoot, G., Somers, S., Roo, C. D., Stoop, D., & Laven, J. S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12123927 · Cited by 12
Colombo, G. E., Pirotta, S., & Sabag, A. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777116 · Cited by 28
“85 While all dietary recommendations should meet macronutrient reference values (protein 20 – 30%, carbohydrates 45 – 65%, fat 20%, saturated fat 20% total daily energy intake), an individualized person-centered approach will likely allow for greater long-term sustainability and health, 86 while…”
BackgroundSkouteris, H., Melder, A., Bailey, C., Morris, H., Garad, R. M., Teede, H. J., & Robinson, T. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667311 · Cited by 10
Self-citationLarge-Scale Evidence-Based Guideline Development Engaging the International PCOS Community
Misso, M. L., Tassone, E. C., Costello, M., Dokras, A., Laven, J. S. E., Moran, L., Teede, H. J., & on behalf of the International PCOS Network (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667312 · Cited by 12
Self-citationGender Medicine in Clinical Radiology Practice
Giacobbe, G., Granata, V., Trovato, P., Fusco, R., Simonetti, I., Muzio, F. D., Cutolo, C., Palumbo, P., Borgheresi, A., Flammia, F., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020223 · Cited by 10
“In addition, because of gender differences, many clinical conditions in the female population are underestimated and/or delayed and may result in poor clinical management [6,7].”
BackgroundPeven, K., Wickham, A. P., Wilks, O., Kaplan, Y. C., Marhol, A., Ahmed, S., Bamford, R., Cunningham, A. C., Prentice, C., Meczner, A., et al. (2023) · JMIR mHealth and uHealth · doi:10.2196/46718 · Cited by 9
“A similar study of patients diagnosed with PCOS found that 33.6% of women reported >2 years time to diagnosis, 47.1% visited ≥ 3 health professionals before a diagnosis was established, and 64.8% were dissatisfied with the diagnostic process [66].”
BackgroundInfluentialBriscoe, S., Coon, J. T., Meléndez‐Torres, G. J., Abbott, R. A., Shaw, L., Nunns, M., & Garside, R. (2023) · BJGP Open · doi:10.3399/bjgpo.2023.0133 · Cited by 9
Livadas, S., Yıldız, B. O., Mastorakos, G. P., Gambineri, A., Pignatelli, D., Giorgino, F., Andersen, M., Obermayer-Pietsch, B., Μacut, D., ESE PCOS Special Interest Group, et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae085 · Cited by 14
Fugal, A., Stanford, J. B., Johnstone, E. B., Kah, K., & Schliep, K. C. (2022) · AJOG Global Reports · doi:10.1016/j.xagr.2022.100070 · Cited by 10
“Am J Obstet Gynecol Glob Rep 2022. the PRAMS targeted sampling scheme, may experience consensus-based15 symptoms for PCOS, including menstrual irregularity and hyperandrogenism, but never receive a formal diagnosis of PCOS.”
BackgroundInfluentialMalin, M. V., & Surekha, T. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20223644 · Cited by 9
Rao, V. S., Peña, A. S., James, A., Phadke, A., Grover, J., Blendis, E., Choudhary, N., & Kampegowda, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1295705 · Cited by 13
“Despite this multifaceted nature, the psychological, emotional, and social aspects associated with PCOS often receive inadequate attention in clinical practice, leaving many adolescents and women dissatis fi ed with the prevailing standard of care (3 – 6).”
BackgroundHow Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?
Jacob, S., & Balen, A. H. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119849605 · Cited by 11
Ryu, K.-J., Park, H., Kim, M. S., Jeong, H. G., & Kim, T. (2024) · Scientific Reports · doi:10.1038/s41598-023-50650-y · Cited by 12
“However, surveys conducted in Western countries indicate that patients are dissatisfied with the counselling they receive related to the screening and management of their CVD risk 25 .”
BackgroundManagement of cardiometabolic complications in polycystic ovary syndrome: Unmet needs
Cardozo, L. L. Y., & Romero, D. G. (2021) · The FASEB Journal · doi:10.1096/fj.202002526rr · Cited by 11
Wright, P. J., Burts, C., Harmon, C., & Corbett, C. F. (2025) · JMIR Infodemiology · doi:10.2196/68469 · Cited by 8
“In a large international cross-sectional study of women with PCOS aged 18 ‐ 45 years (N=1256), approximately 65% (n=816) reported dissatisfaction with information received from health care professionals and the need for self-directed research [55].”
Wattar, B. H. A., Teh, J. J., Clarke, S. A., Abbara, A., Morman, R., Wilcox, A., & Talaulikar, V. S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15038 · Cited by 10
“7 Many health regulators and lay consumers groups are now advocating the adoption of a lifelong approach to caring for women with PCOS, which offers holistic care and addresses their health needs from menarche to menopause and beyond within multi ‐ disciplinary teams (MDT) comprised of primary,…”
BackgroundDiagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review
Zhang, Y., Yang, K., Fan, T., Zheng, D., & Liu, H. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s506498 · Cited by 12
“85 Psychosocial factors should also be considered.”
Ding, R., Heng, Z., Yan, X., Liu, Y., Guo, Y., Tan, H., Wang, X., Wang, Y., & Wang, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.984653 · Cited by 11
“To be more specific, challenges include the risk of under-diagnosis, delayed and/or poor diagnosis experiences (7), and over-diagnosis, as well as the additional risk of the use of inconsistent non-evidencebased approaches to PCOS diagnosis and management (8).”
BackgroundTay, C. T., Williams, F., Mousa, A., Teede, H., & Burgert, T. S. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777086 · Cited by 8
“7 Speci fi cally, this study and others found that healthcare professional communication lacked recommendations for lifestyle modi fi cations/weight management, 7,16 discussion of long-term complications, extension of emotional support/ counseling, 17 and empathy.”
BackgroundInfluentialSelf-citationWeedin, E. A., Burks, H. R., Yu, X., Li, H. L., Aston, C. E., Kem, D. C., & Craig, L. B. (2020) · F&S Reports · doi:10.1016/j.xfre.2020.09.015 · Cited by 8
“The absence of a simple diagnostic test for PCOS frequently results in multiple specialist visits that, in turn, increase the cost of health care, delay diagnosis and treatment, and add additional emotional and psychologic stress for the those affected by the disease (5).”
BackgroundShirin, S., Murray, F., Goshtasebi, A., Kalidasan, D., & Prior, J. C. (2021) · Medicina · doi:10.3390/medicina57101024 · Cited by 9
“Women living with PCOS face many health problems, some of which have sociocultural dimensions, such as difficulty in losing weight [3], excess facial hair, acne, [4] alopecia, and infertility [3], with resulting increases in depression and anxiety [5].”
BackgroundPereira-Eshraghi, C., Tao, R., Chiuzan, C. C., Zhang, Y., Shen, W., Lerner, J. P., Oberfield, S. E., & Sopher, A. B. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.008 · Cited by 12
“Diagnostic evaluation of PCOS has been estimated to account for only 2% of the total mean annual cost of PCOS in women of reproductive age in the United States, which is>4 billion dollars per year (11).”
BackgroundLai, W., Shen, N., Zhu, H., He, S., Yang, X., Lai, Q., Li, R., Ji, S., & Chen, L. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13250 · Cited by 9
“1%) before a confirmed diagnosis of PCOS was established.(15) The main reason is that obtaining a diagnosis of PCOS by perfectly meeting the Rotterdam diagnostic criteria(16) is often a tortuous and lengthy process.”
BackgroundPiltonen, T., Kinnunen, J., Komsi, E. K., Kangasniemi, M. H., Luiro, K., Rajecki, M., Jokelainen, J. J., Kiviniemi, E., Allegranza, D., Hund, M., et al. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.05.147 · Cited by 9
Wang, Y., Bao, H., Cong, J., & Qu, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1553684 · Cited by 8
Lin, L., Li, W., Xu, B., Li, Y., Li, J., Kong, X., & Du, X. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01002-1 · Cited by 15
“Early screening programs are essential, especially in low SDI regions where adolescent healthcare is often inadequate [27].”
InfluentialExploring the Experiential Journey of Women with PCOS Across the Lifespan: A Qualitative Inquiry
Wright, P. J., Dawson, R. M., & Corbett, C. F. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s467737 · Cited by 9
Piltonen, T., Ohtamaa, M., Arffman, R. K., Vuokila, L., Hurskainen, E., Männikkö, M., Huilaja, L., Sinikumpu, S., Rautio, T., Kilpivaara, K., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae230 · Cited by 7
Cochran, L., Nadolny, R., Garcia, K., Kluglein, K. A., Yagoda, A., Gandhi, P., Dressel, J., Prol, B., Peralta, R., Shipp, A., et al. (2024) · Cureus · doi:10.7759/cureus.70501 · Cited by 11
“Up to one-third of patients reported a delay of over two years before receiving a diagnosis of PCOS, and 40% reported visiting three or more physicians in the process [6].”
BackgroundPreliminary Detection of Cyst Formation in Ovary Using Advanced Computer Vision Approach
Ragit, N., Zanke, P., Jaipurkar, M., Agrawal, R., Gaurihar, M., & Dhule, C. (2024) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt61001.2024.10723845 · Cited by 7
“Various individuals might develop different PCOS symptoms [7].”
BackgroundDelphi consensus on the diagnostic criteria of polycystic ovary syndrome
Facchinetti, F., Gambineri, A., Aimaretti, G., Ferlin, A., Laganà, A. S., Moghetti, P., Oliva, M. M., Unfer, V., & Colao, A. A. L. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02533-4 · Cited by 10
Assessment and Management of Women with Polycystic Ovary Syndrome (PCOS)
Garad, R. M., Shorakae, S., & Teede, H. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_39 · Cited by 9
Self-citationClassification of Polycystic Ovary Syndrome Based on Correlation Weight Using Machine Learning
Marreiros, M., Ferreira, D. L. A., Neto, C., Witarsyah, D., & Machado, J. M. (2022) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-9172-7.ch006 · Cited by 9
Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes
Actkins, K. V., Jean-Pierre, G., Aldrich, M. C., Edwards, D. R. V., & Davis, L. K. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010764 · Cited by 8
“heterogenous presentation of symptoms, and the prevalent comorbidities that reside outside of 102 diagnostic requirements patients often spend years seeking a diagnosis or worse, may be one 103 of the 75% of females estimated to be undiagnosed [4,5].”
BackgroundNatural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
Sattler, L.-M., Schniewind, H. A., Minich, W. B., Haudum, C. W., Niklowitz, P., Münzker, J., Kovács, G. L., Reinehr, T., Obermayer-Pietsch, B. M., & Schomburg, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249639 · Cited by 10
“However, around one half of the affected women are on a year-long journey with three or more specific health professionals needed for establishing the diagnosis, causing dissatisfaction and disappointment with the current medical care and information on PCOS [7].”
BackgroundJarrett, B. Y., Lin, A., & Lujan, M. E. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.10.001 · Cited by 8
Polycystic Ovary Syndrome: A Comprehensive Exploration of Diagnosis Experience in Saudi Women
Alqntash, N., AlZabin, A. K., Almajed, E. H., Alotaibi, K. M., Alhindi, G., Ali, S. I., & Bakhsh, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175305 · Cited by 14
Jiang-yu, H., Manzoor, M., Siddique, R., Manzoor, H., Moazzam, S., Bazmi, R. R., & Hussain, L. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/8015756 · Cited by 6
Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina
Djedjibegovíc, J., Marjanović, A., Kobilica, I., Turalić, A., Lugusić, A., & Šober, M. (2020) · AIMS Public Health · doi:10.3934/publichealth.2020041 · Cited by 6
“In this context, it is worth noting that one recent study conducted among 1385 women from 32 countries worldwide found that over half of women reported receiving lifestyle management information at PCOS diagnosis, but only 12% were satisfied with it [29].”
Albezrah, N. A., & Arein, F. (2019) · Saudi Journal for Health Sciences · doi:10.4103/sjhs.sjhs_16_19 · Cited by 8
Estermann, J., Bitterlich, N., Weidlinger, S., Bachmann, A., Sourouni, M., & Stute, P. (2023) · Journal of Women s Health · doi:10.1089/jwh.2022.0497 · Cited by 8
“5 Apart from late diagnosis, there were also deficiencies in diagnostic procedures and information comprehensiveness.”
Piltonen, T., Allegranza, D., Hund, M., Buck, K., Sillman, J., & Arffman, R. K. (2024) · JMIR Research Protocols · doi:10.2196/48854 · Cited by 10
“Thus, there is significant underdiagnosis of PCOS [18] along with a substantial delay in receiving a diagnosis [19-22]; therefore, an unmet medical need exists for a diagnostic test to determine PCOM without the need for TVUS.”
Kozica, S. L., Teede, H. J., & Garad, R. M. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667308 · Cited by 6
Self-citationReporting quality of polycystic ovary syndrome practice guidelines based on the RIGHT checklist
Li, H., Zhang, Y., Lu, L., & Wei, Y. (2020) · Medicine · doi:10.1097/md.0000000000022624 · Cited by 6
“This confusion leads to delayed diagnosis, and patients report poor diagnosis experiences and dissatisfaction with care internationally.([4]) Trustworthy CPGs based on an important systematic review of the literature, provide ratings of the quality of evidence and the strength of recommendations, optimize patient valu…”
BackgroundCommentary: Mendelian randomization and women’s health
Censin, J. C., Bovijn, J., Holmes, M. V., & Lindgren, C. M. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz141 · Cited by 6
“Despite this, most PCOS studies have had small sample sizes, and survey data suggest that over a third of PCOS patients have to wait more than 2 years for diagnosis.(11) At the same time, comorbidities are under-diagnosed and under-treated, despite substantial effects on patient health and quality of life.”
ResultKallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study
Yurtkal, A., & Canday, M. (2024) · Diagnostics · doi:10.3390/diagnostics14141553 · Cited by 9
Demis, A., Kiconco, S., Earnest, A., Khomami, M. B., Dhungana, R. R., Azziz, R., Сутурина, Л. В., Zhao, X., Gambineri, A., Tehrani, F. R., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04221-9 · Cited by 10
“This contributes to delayed or inaccurate diagnosis of PCOS, hindering timely and appropriate interventions to limit complications and treat the condition [12, 32–35].”
Self-citationEarly diagnosis in polycystic ovary syndrome
Blanco, C. E. (2022) · The Nurse Practitioner · doi:10.1097/01.npr.0000873528.58247.9e · Cited by 6
“found that it took greater than 2 years for one-third of the participants to receive a PCOS diagnosis, and almost half required three or more health professionals to establish a diagnosis.(6) The same study found that most of the women were dissatisfi ed with the diagnosis experience and level of information received.”
BackgroundWang, X., Han, H., Shi, X., Nie, X., Zhu, R., Jin, J., & Zhou, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1391826 · Cited by 7
Pace, L. A., Kummer, N., Wallace, M., & Azziz, R. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01702-9 · Cited by 7
Wang, W., Barkat, M. Q., Amin, S., Alshammari, A., Albekairi, N. A., Manzoor, H., Chauhdary, Z., Bazmi, R. R., Hussain, L., & Chen, Q. (2024) · Journal of Food Biochemistry · doi:10.1155/jfbc/1184854 · Cited by 8
The role of interviewing in endocrine practice
Sonino, N., Fava, G. A., Aron, D. C., & Guidi, J. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02565-w · Cited by 6
“In practice, many endocrine disorders are diagnosed after a considerable delay from the onset of symptoms and such delay may entail profound psychological effects on the patient, as in the case of Cushing’s syndrome [31] and in polycystic ovary syndrome [32].”
Boomidevi, R., & Usha, S. (2021) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-16-0081-4_47 · Cited by 6
Gill, L. A., Coborn, J., Hoovler, A., & Sherif, K. (2023) · Journal of Women s Health · doi:10.1089/jwh.2022.0471 · Cited by 10
“13,15,16 A small qualitative survey in the United States found that women with PCOS experienced frustration with HCPs, confusion about the diagnostic process (long duration and number of HCPs seen) and lack of treatment plans, and a phase of searching for answers followed by gaining control.”
Uptake of the core outcome set on polycystic ovary syndrome before and after its publication
Li, W., Li, G., Chi, H., Wang, H., & Zeng, L. (2023) · Human Reproduction · doi:10.1093/humrep/dead149 · Cited by 6
“…there is a paucity of scales specifically designed to assess depression, anxiety and eating disorders in PCOS populations (Al Wattar et al. , 2021), and longitudinal studies are confronted with challenges in conducting long-term follow-up (Gibson-Helm et al. , 2017; Kiconco et al. , 2022a).”
Polycystic ovary syndrome v.2023: Simplified diagnostic criteria for an East Asian phenotype
Yong, E., Teoh, W. S., & Huang, Z. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.202369 · Cited by 7
“33 In Singapore, a survey of 160 gynaecologists, endocrinologists, family physicians and general practitioners found that a large percentage (60.5”
BackgroundInfluentialPace, L. A., Waldeck, J., Chan, J. L., Pisarska, M. D., & Azziz, R. (2024) · Journal of Women s Health · doi:10.1089/jwh.2024.0186 · Cited by 5
“14,15 It is therefore unsurprising that PCOS patient dissatisfaction with clinical care is high, particularly as it relates to health care providers, the diagnostic process, and initial treatment.”
Feferkorn, I., Badeghiesh, A. M., Mills, G., Baghlaf, H. A., & Dahan, M. H. (2021) · Human Reproduction · doi:10.1093/humrep/deab145 · Cited by 5
A Comprehensive PCOS Research and Guideline Translation Program to Improve Practice
Ramasamy, V. A., Garad, R. M., & Boyle, J. A. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1733916 · Cited by 5
Avery, J., Moran, L., Moore, V., Fernandez, R. C., Whitrow, M. J., Stocks, N. P., Gill, T. K., Musker, M., Davies, M. J., & Rumbold, A. R. (2019) · Fertility & Reproduction · doi:10.1142/s2661318219500154 · Cited by 5
Gaps and opportunities in polycystic ovary syndrome care—a qualitative study
Zhang, A. Z., Sehrt, M. N., Ley, S. A., Ross, K. V., Phimphasone‐Brady, P., & McKenney, K. M. (2025) · F&S Reports · doi:10.1016/j.xfre.2025.05.011 · Cited by 8
“However, prior qualitative studies revealed that participants with PCOS are dissatis fi ed with the information shared by providers at the time of diagnosis and fi nd it dif fi cult to recall later, leading to discontent with providers and their care experience (7 – 9).”
Linking altered gut microbiome to polycystic ovarian syndrome through immune mediated pathway
Pathak, V. A., Kshirsagar, S. J., & Deokar, G. S. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104648 · Cited by 8
Peebles, E., Wang, Z., Dracup, E., Sarcione, C., Curry, C. L., Abrams, K., Onnela, J.-P. “., Williams, M. A., Hauser, R. B., Coull, B. A., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1585628 · Cited by 5
Parsaei, M., Karimi, E., Barkhordarioon, A., Yousefi, M., & Tarafdari, A. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02719-y · Cited by 9
“Despite its prevalence, diagnosis is often delayed; up to 75% of women in the U.S. remain undiagnosed, and about one in four experience delays of two years or more [7–9].”
“Can Anyone Tell Me…”. Online Health Communities in Diabetes Self-Management in Poland and Italy
Ardissone, A., Leonowicz-Bukała, I., & Struck-Peregończyk, M. (2024) · Health Communication · doi:10.1080/10410236.2024.2348842 · Cited by 5
Navigating the Future of PCOS Treatment: The Precision Medicine Paradigm
Sunil, A. T., Jo, C., Sanigha, P. S., Kolasseri, A. E., Tamizhselvi, R., & Jayanthi, S. (2024) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921331801240820115132 · Cited by 6
Sacca, L., Lobaina, D., Knopf, E., Burgoa, S., Jimenez, S., Okwaraji, G., Etzel, M., Vardanyan, V., Tharp, M. E., Rao, M., et al. (2024) · Clinics and Practice · doi:10.3390/clinpract14050131 · Cited by 7
Assessing the uptake of infertility core outcome set in IVF randomized controlled trials
Li, W., Jia, N., Chi, H., Zhan, S., & Zeng, L. (2024) · Human Reproduction · doi:10.1093/humrep/deae255 · Cited by 5
Polyzystisches Ovarsyndrom – praktische Umsetzung der internationalen Leitlinie
Segerer, S. E., & Keck, C. (2021) · Der Gynäkologe · doi:10.1007/s00129-020-04732-x · Cited by 4
Pregnancy outcome in PCOS patients: The effects of letrozol combined with exercise
Manteghi, G., Shahraki, Z., Moghadam, M. N., & Ghanbarpour, M. H. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00142-z · Cited by 5
Mei, L. L., Abu, M. A., Chew, K. T., Ismail, A., Zainuddin, A. A., & Azurah, A. G. N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848860 · Cited by 7
Armstrong, J., Cortes, C. N., Hawkins, K. C., & Younis, A. I. (2022) · Gynecology & Reproductive Health · doi:10.33425/2639-9342.1203 · Cited by 4
Kim, A. E., Lee, I. T., Ottey, S., & Dokras, A. (2024) · F&S Reports · doi:10.1016/j.xfre.2024.05.004 · Cited by 7
“(17).”
MethodSelf-citationDiagnosis and management of polycystic ovary syndrome: Perspectives of clinicians in Singapore
Teoh, W. S., Ramu, D., Indran, I. R., Chua, M. W. J., Thu, W. P. P., & Yong, E. (2022) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2021474 · Cited by 5
Kaundal, A., Renjhen, P., & Kumari, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1378647/v1 · Cited by 4
Garay, O. U., Olziersky, A.-M., Laven, J. S. E., Mawson, R. L., Piltonen, T., Franks, S., & Sillman, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326162 · Cited by 4
“In the UK NHS, women are currently referred to diagnostic centers for TVUS due to the long waiting periods in the primary care setting; delayed or missed PCOS diagnoses occur because of this [18,19].”
InfluentialParker, M. N., Wiggins, S. P., Thornton, J. A., Sunderland, K. W., Brydum, R., Funk, W., Pav, V., & Klein, D. A. (2025) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2025.06.008 · Cited by 4
Bloom, B. E., Bragg, M. A., Jay, M. R., Harel, D., Cline, C., Crowe, M., Montoya, A., Muthuramalingam, S., Santana, R., & Albert, S. L. (2025) · Journal of Medical Internet Research · doi:10.2196/66400 · Cited by 6
“Given the challenges of PCOS diagnoses and the limited information and treatment options for PCOS, researchers and clinicians alike have found dissatisfaction among their female patients who have been diagnosed with PCOS [34].”
Gong, Y., Wang, D., Wu, C., Ni, M., Li, S.-L., Liu, Y., Shen, Z.-Y., Su, Z., Liu, X., Zhou, H.-P., et al. (2026) · IEEE Signal Processing Letters · doi:10.1109/lsp.2025.3636719 · Cited by 3
“often leading to delayed diagnoses [4], [5].”
Wang, Y., Chen, J., Dong, H., Ma, R., Zou, Y., Wang, W., Zheng, Q., Feng, Y., Tan, Z., Zeng, X., et al. (2022) · BioMed Research International · doi:10.1155/2022/9778678 · Cited by 3
“There is a strong relationship between obesity and PCOS prevalence [6].”
BackgroundRetractedZhao, Y., Xiong, S., Liu, T., Shu, J., Zhu, T., Li, S., Zhong, M., Zhao, S., Huang, X., & Liu, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355703 · Cited by 7
“Furthermore, TWL%, rather than preoperative BMI, correlated with the remission after SG. Irregular menstruation is a key concern in patients with PCOS even beyond infertility partially because of the increased risk of endometrial cancer (17).”
BackgroundHofmann, K., Oehler, M., Ruckes, C., Dionysopoulou, A., Stewen, K., Schiestl, L. J., Degirmenci, Y., Theis, S., Skala, C., Hasenburg, A., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40431 · Cited by 5
Global approach to polycystic ovary syndrome in Africa
Sokwala, S. B. M. R., & Dodia, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00038-4 · Cited by 9
Fossey, B., McCaffery, K. J., Cvejic, E., Jansen, J., & Copp, T. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20115998 · Cited by 7
The Experience of Living With Polycystic Ovary Syndrome in the Military
Hopkins, D., Walker, S. C., Wilson, C., Siaki, L., Phillips, A. K., & Wallen, G. R. (2023) · Military Medicine · doi:10.1093/milmed/usad241 · Cited by 6
Understanding Polycystic Ovary Syndrome (PCOS): Symptoms, Diagnosis, Treatment and Future Directions
Chakravorty, T. A. (2023) · The Physician · doi:10.38192/1.8.2.3 · Cited by 9
Nelson, K., Shirin, S., Kalidasan, D., & Prior, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0296377 · Cited by 4
Impact of Polycystic Ovary Syndrome (PCOS) on Fertility and Pregnancy Outcomes
Puthilibai, G., Devatarika, V., Gokul, V., Chinnaraj, P., Hariram, V., & Lazha, A. (2023) · International Conference on Intelligent Computing and Control for Engineering and Business Systems (ICCEBS) · doi:10.1109/iccebs58601.2023.10448962 · Cited by 4
“First depicted by Stein and Leventhal in 1935, PCOS is portrayed by a heavenly body of side effects, including hyperandrogenism, feminine inconsistencies, and polycystic ovaries [2].”
BackgroundDisparities in the Diagnosis and Management of Polycystic Ovarian Syndrome in Adolescents
Waldrop, S., Buenaventura, M., Reyes, K. J. C., & Stanford, F. C. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.02.016 · Cited by 4
Yuk, J., Noh, J. H., Han, G. H., Yoon, S. H., & Kim, M. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70560 · Cited by 3
Polycystic Ovarian Syndrome: An Autobiographical Case Report of an Often Overlooked Disorder
Patel, V. H. (2022) · Cureus · doi:10.7759/cureus.21171 · Cited by 6
“At least a third of women reported visiting multiple clinicians before a diagnosis is established [3].”
BackgroundEarly phenotypes in polycystic ovary syndrome: some answers, more questions
Torchen, L. C. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.020 · Cited by 3
Khan, M., Jaman, A., Ahmed, M. F., & Das, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4918589/v2 · Cited by 2
The Evolving Role of Anti-Müllerian Hormone Measurements in Clinical Practice
Zhang, X. S., & Noguez, J. H. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf096 · Cited by 3
Zhang, B., & Lalor, J. (2025) · Journal of Advanced Nursing · doi:10.1111/jan.70265 · Cited by 14
Gadiraju, M., Kim, J. Y., Green, E. M., Uribe, A. L. M., Chang, H., Burgert, T. S., Olfert, M. D., & Brink, H. V. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1628853 · Cited by 3
Metadata
- Authors
- Gibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A.
- Affiliations
- Monash University (AU)
- Northwestern University (US)
- University of Pennsylvania (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-12
- Volume
- 102
- Issue
- 2
- Pages
- jc.2016-2963
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6283441
- OpenAlex
- W2558741448
- Semantic Scholar
- 40df9dea1b1d66c489276ae630b48e438c7595a9
- Cited by
- 428
- References
- 38
- Citations by year
- 2026: 33 · 2025: 59 · 2024: 68 · 2023: 69 · 2022: 47 · 2021: 53 · 2020: 32 · 2019: 29 · 2018: 30 · 2017: 7 · 2016: 1
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- Victoria University of Wellington
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, delayed diagnosis, patient satisfaction, patient information, patient concerns, menstrual irregularity, infertility, patient experience, women's health
- MeSH terms
- Adolescent, Adult, Cross-Sectional Studies, Female, Humans, Patient Education as Topic, Polycystic Ovary Syndrome, Surveys and Questionnaires, Global Health, Patient Satisfaction, Consumer Health Information, Young Adult, Delayed Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.